Enantio-selectivity of human nucleoside monophosphate kinases.
Over recent years, there has been a renewed interest in the development of L-nucleosides as safe and efficacious drugs for the treatment of viral infections. Biological activity of these compounds requires phosphorylation to their triphosphate form, involving nucleoside monophosphate kinases in the second step. In order to characterize the activation pathway of L-nucleosides of the pyrimidine series, we studied the enantio-selectivity of human uridylate-cytidylate and thymidylate kinases. The results showed that these enzymes are only weakly enantio-selective and are thus probably involved in the activation of L-nucleosides in vivo. An activation pathway for telbivudine (L-dT) was therefore proposed.
Alexandre
J A C
JA
Laboratoire d'Enzymologie Moléculaire et Fonctionnelle, FRE2852-CNRS-Université Paris 6, 4 place Jussieu, F-75005 Paris, France.
Roy
B
B
Topalis
D
D
Périgaud
C
C
Deville-Bonne
D
D
D000998:Antiviral Agents / Q000737:chemistry*; D006801:Humans; D009703:Nucleoside-Phosphate Kinase / Q000737:chemistry*; D009705:Nucleosides / Q000378:metabolism; D011741:Pyrimidine Nucleosides / Q000737:chemistry*; D011744:Pyrimidinones / Q000378:metabolism; D013237:Stereoisomerism; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives
D000998:Antiviral Agents; D009705:Nucleosides; D011741:Pyrimidine Nucleosides; D011744:Pyrimidinones; D000077712:Telbivudine; D009703:Nucleoside-Phosphate Kinase; D013936:Thymidine